Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 9726

1.

Ectromelia Virus Disease Characterization in the BALB/c Mouse: A Surrogate Model for Assessment of Smallpox Medical Countermeasures.

Garver J, Weber L, Vela EM, Anderson M, Warren R, Merchlinsky M, Houchens C, Rogers JV.

Viruses. 2016 Jul 22;8(7). pii: E203. doi: 10.3390/v8070203.

2.

Vacca pox to pexa vec: John Hunter's and Edward Jenner's contribution to oncolytic virotherapy.

Dave RV.

J Surg Res. 2016 Jul;204(1):228-31. doi: 10.1016/j.jss.2016.04.025. Epub 2016 Apr 23. Review. No abstract available.

PMID:
27451890
3.

[THE USE OF THE MODEL MOUSE ICR--VARIOLA VIRUS FOR EVALUATION OF ANTIVIRAL DRUG EFFICACY].

Titova KA, Sergeev Al A, Kabanov AS, Bulychev LE, Sergeev Ar A, Galakhova DO, Shishkina LN, Zamedyanskaya AS, Nesterov AE, Glotov AG, Taranov OS, Omigov VV, Agafonov AP, Sergeev AN.

Vopr Virusol. 2016;61(2):79-84. Russian.

PMID:
27451500
4.

[EVALUATION OF THE HUMAN SENSITIVITY TO SMALLPOX VIRUS BY THE PRIMARY CULTURES OF THE MONOCYTE-MACROPHAGES].

Zamedyanskaya AS, Titova KA, Sergeev AA, Kabanov AS, Bulychev LE, Sergeev AA, Galakhova DO, Nesterov AE, Nosareva OV, Shishkina LN, Taranov OS, Omigov VV, Agafonov AP, Sergeev AN.

Vopr Virusol. 2016;61(2):69-73. Russian.

PMID:
27451498
5.

Paediatric Virology in the Hippocratic Corpus.

Mammas IN, Spandidos DA.

Exp Ther Med. 2016 Aug;12(2):541-549. Epub 2016 Jun 3.

6.

Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions.

Mezache L, Magro C, Hofmeister C, Pichiorri F, Sborov D, Nuovo GJ.

Appl Immunohistochem Mol Morphol. 2016 Jul 19. [Epub ahead of print]

PMID:
27438510
7.

Beyond Primates: Research Protections and Animal Moral Value.

Walker RL.

Hastings Cent Rep. 2016 Jul;46(4):28-30. doi: 10.1002/hast.602.

PMID:
27417867
8.

Emerging diseases - The monkeypox epidemic in the democratic repubic of the congo.

Kantele A, Chickering K, Vapalahti O, Rimoin AW.

Clin Microbiol Infect. 2016 Jul 9. pii: S1198-743X(16)30228-2. doi: 10.1016/j.cmi.2016.07.004. [Epub ahead of print] No abstract available.

PMID:
27404372
9.

Adventures of a Female Medical Detective: In Pursuit of Smallpox and AIDS.

Blaschke AJ.

Clin Infect Dis. 2016 Jul 8. pii: ciw453. [Epub ahead of print] No abstract available.

PMID:
27402821
10.

British merchant seafarers 1900-2010: A history of extreme risks of mortality from infectious disease.

Roberts SE, Carter T.

Travel Med Infect Dis. 2016 Jul 7. pii: S1477-8939(16)30076-X. doi: 10.1016/j.tmaid.2016.06.009. [Epub ahead of print]

PMID:
27395763
11.

Agility in Adversity: Vaccines on Demand.

De Groot AS, Moise L, Olive D, Einck L, Martin W.

Expert Rev Vaccines. 2016 Jul 7. [Epub ahead of print]

PMID:
27389971
12.

Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971-2010.

Rieckmann A, Villumsen M, Sørup S, Haugaard LK, Ravn H, Roth A, Baker JL, Benn CS, Aaby P.

Int J Epidemiol. 2016 Jul 5. pii: dyw120. [Epub ahead of print]

13.

New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.

Schulze K, Ebensen T, Riese P, Prochnow B, Lehr CM, Guzmán CA.

Curr Top Microbiol Immunol. 2016 Jul 2. [Epub ahead of print]

PMID:
27370343
14.

Long-term safety of replication-defective smallpox vaccine (MVA-BN) in atopic eczema and allergic rhinitis.

Darsow U, Sbornik M, Rombold S, Katzer K, von Sonnenburg F, Behrendt H, Ring J.

J Eur Acad Dermatol Venereol. 2016 Jun 29. doi: 10.1111/jdv.13797. [Epub ahead of print]

PMID:
27357167
15.
16.

Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister Vaccine Variant Used during a Smallpox Eradication Campaign in Brazil.

Assis F, Trindade G, Drumond B, Frace M, Sammons S, Emerson G, Li Y, Carroll D, Batra D, Abrahão J, Kroon E.

Genome Announc. 2016 Jun 23;4(3). pii: e00536-16. doi: 10.1128/genomeA.00536-16.

17.

Dismantling the Taboo against Vaccines in Pregnancy.

de Martino M.

Int J Mol Sci. 2016 Jun 7;17(6). pii: E894. doi: 10.3390/ijms17060894. Review.

18.

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.

Greenberg RN, Hay CM, Stapleton JT, Marbury TC, Wagner E, Kreitmeir E, Röesch S, von Krempelhuber A, Young P, Nichols R, Meyer TP, Schmidt D, Weigl J, Virgin G, Arndtz-Wiedemann N, Chaplin P.

PLoS One. 2016 Jun 21;11(6):e0157335. doi: 10.1371/journal.pone.0157335. eCollection 2016.

19.

Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.

Findlay F, Proudfoot L, Stevens C, Barlow PG.

Pathog Glob Health. 2016 Jun 17:1-11. [Epub ahead of print]

PMID:
27315342
20.

A generalized-growth model to characterize the early ascending phase of infectious disease outbreaks.

Viboud C, Simonsen L, Chowell G.

Epidemics. 2016 Jun;15:27-37. doi: 10.1016/j.epidem.2016.01.002. Epub 2016 Feb 1.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk